F-group (family)
7577.1.1.5 SHMT
Ligands and drugs
1,317
Member domains
373
with ligand contacts (≤ 4 Å)
28.3% of members
333
with DrugDomain annotations
25.3% of members
310
with a DrugBank compound
23.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7577.1.1.5 belongs to X-group 7577 PLP-dependent transferases, which binds 7.7 ligand superclasses per 20 proteins, broader than 51% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00114 | PLP | Pyridoxal phosphate | 126 |
| DB02824 | PLG | N-Pyridoxyl-Glycine-5-Monophosphate | 108 |
| DB00145 | GLY | Glycine | 49 |
| DB00133 | SER | Serine | 24 |
| DB11596 | FFO | Levoleucovorin | 22 |
| DB03929 | DSN | D-Serine | 10 |
| DB00563 | MTX | Methotrexate | 8 |
| DB02800 | THF | 5-hydroxymethyl-5,6-dihydrofolic acid | 5 |
| DB03256 | FON | (6R)-Folinic acid | 5 |
| DB00642 | LYA | Pemetrexed | 4 |
| DB03345 | BME | Mercaptoethanol | 3 |
| DB03619 | DXC | Deoxycholic acid | 3 |
| DB00116 | — | — | 2 |
| DB02142 | PMP | Pyridoxamine-5'-Phosphate | 2 |
| DB02329 | CBO | Carbenoxolone | 2 |
| DB11256 | THH | Levomefolic acid | 2 |
| DB12769 | DDF | Lometrexol | 2 |
| DB01055 | — | Mimosine | 1 |
| DB02067 | — | — | 1 |
| DB03226 | ETF | Trifluoroethanol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PLP | PYRIDOXAL-5'-PHOSPHATE | 134 |
| PLG | N-GLYCINE-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YL-METHANE] | 123 |
| CL | CHLORIDE ION | 80 |
| GLY | GLYCINE | 52 |
| PLS | [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL]-SERINE | 23 |
| SER | SERINE | 23 |
| FFO | N-[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid | 22 |
| DSN | D-SERINE | 10 |
| MTX | METHOTREXATE | 8 |
| NAmetal | SODIUM ION | 8 |
| FON | N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid | 5 |
| 2BO | N-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)-L-threonine | 4 |
| 5M5 | (4R)-6-azanyl-4-[3-(hydroxymethyl)-5-phenyl-phenyl]-3-methyl-4-propan-2-yl-1H-pyrano[2,3-c]pyrazole-5-carbonitrile | 4 |
| DTH | D-THREONINE | 4 |
| EVM | L-Serine, N-[[3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methylene] | 4 |
| LYA | 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID | 4 |
| THF | 5-HYDROXYMETHYLENE-6-HYDROFOLIC ACID | 4 |
| 1W9 | (2R)-2-[(E)-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylideneamino]-3-oxidanyl-propanoic acid | 3 |
| 33G | (4S)-6-amino-4-(5-cyano-3'-fluorobiphenyl-3-yl)-4-cyclobutyl-3-methyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | 3 |
| 8A0 | (4~{S})-6-azanyl-3-methyl-4-[3-(2-methylphenyl)-5-(trifluoromethyl)phenyl]-4-propan-2-yl-2~{H}-pyrano[2,3-c]pyrazole-5-carbonitrile | 3 |